This Collection supports and amplifies research related to SDG 3: Good Health & Wellbeing and SDG 17: Partnerships for the Goals. The rapid evolution of artificial intelligence (AI) is reshaping the ...

For more than a decade, artificial intelligence has been touted as a way to dramatically accelerate drug discovery. Yet ...

Generative artificial intelligence is moving from the margins of pharma into the center of how new medicines are imagined, built, and tested. Instead of tweaking existing compounds, these models can ...

The findings, published in the journal PLOS One describe how researchers used VR to understand how common medications work on a molecular level. Many drugs are small molecules, and discovering new ...

Eli Lilly chief information and digital officer Diogo Rau was recently involved in some experiments in the office, but not the typical drug research work that you might expect to be among the lab ...

Researchers at Rice University used light-activated molecular machines to trigger intercellular calcium wave signals which they say demonstrates a new strategy for controlling cellular activity. The ...

Experts have been raising concerns about “AI washing.” One of these experts, futurist Bernard Marr, has said that AI washing “involves exaggerating the capabilities of a product or service that is ...

Google DeepMind announced the launch of AlphaProteo, an AI system to help biological and health researchers design novel, high-strength proteins that bind to target molecules with accuracy and ...

Drug discovery happens to be among the most expensive and laborious processes across scientific disciplines. Developing just ...

Some proteins in the human body are easy to block with a drug; they have an obvious spot in their structure where a drug can fit, like a key in a lock. But other proteins are more difficult to target, ...